Themis Medicare Limited (NSE:THEMISMED)
India
· Delayed Price · Currency is INR 129.20
-2.47 (-1.88%)
Jun 27, 2025, 3:29 PM IST
Themis Medicare Revenue
In the fiscal year ending March 31, 2025, Themis Medicare had annual revenue of 4.06B INR with 6.22% growth. Themis Medicare had revenue of 717.02M in the quarter ending March 31, 2025, a decrease of -26.70%.
Revenue
4.06B
Revenue Growth
+6.22%
P/S Ratio
2.99
Revenue / Employee
2.69M
Employees
1,509
Market Cap
12.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.06B | 237.51M | 6.22% |
| Mar 31, 2024 | 3.82B | 274.38M | 7.74% |
| Mar 31, 2023 | 3.54B | -402.91M | -10.21% |
| Mar 31, 2022 | 3.95B | 1.64B | 71.07% |
| Mar 31, 2021 | 2.31B | 290.82M | 14.43% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Mankind Pharma | 122.07B |
| Aurobindo Pharma | 317.24B |
| Fortis Healthcare | 77.83B |